HealthEquity (HQY)
(Delayed Data from NSDQ)
$91.06 USD
-5.94 (-6.12%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $91.01 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, HealthEquity, Inc. has a PEG ratio of 1.41 compared to the Medical Services industry's PEG ratio of 1.52.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HQY 91.06 -5.94(-6.12%)
Will HQY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HQY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HQY
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Top Stock Reports for Apple, JPMorgan Chase & Visa
HQY: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
HealthEquity (HQY) Upgraded to Buy: Here's Why
Other News for HQY
ClearBridge Small Cap Fund Q2 2025 Commentary
Fidelity Small Cap Index Fund Q2 2025 Commentary
Fidelity Small Cap Growth Fund Q2 2025 Commentary
Baron Health Care Fund Q2 2025 Shareholder Letter
Raymond James Raises Price Target for HealthEquity (HQY) to $120 | HQY Stock News